Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 1 |
2024 | 1 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Favorable outcomes of NPM1mut AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance.
Blood Cancer J. 2023 Aug 22;13(1):128. doi: 10.1038/s41408-023-00898-4.
Blood Cancer J. 2023.
PMID: 37607920
Free PMC article.
No abstract available.
Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies.
Raghuwanshi S, Zhang X, Arbieva Z, Khan I, Mohammed H, Wang Z, Domling A, Camacho CJ, Gartel AL.
Raghuwanshi S, et al.
Cell Death Discov. 2024 May 2;10(1):211. doi: 10.1038/s41420-024-01929-0.
Cell Death Discov. 2024.
PMID: 38697979
Free PMC article.
Item in Clipboard
Cite
Cite